Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher M Brackett

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Current Medicinal Chemistry|August 12, 2020
Current Status of SUMOylation InhibitorsChristopher M Brackett, Brian S J Blagg
Medicinal Research Reviews|July 21, 2022
The biology and inhibition of glucose-regulated protein 94/gp96Kyler W Pugh, Marim Alnaed, Christopher M Brackett, et al.
Medchemcomm|November 20, 2012
The discovery of N-1 substituted 2-aminobenzimidazoles as zinc-dependent S. aureus biofilm inhibitorsErick A Lindsey, Christopher M Brackett, Trey Mullikin, et al.
ACS Medicinal Chemistry Letters|November 20, 2020
Synthesis and Evaluation of Ginkgolic Acid Derivatives as SUMOylation InhibitorsChristopher M Brackett, Ana García-Casas, Sonia Castillo-Lluva, et al.
Drug Development Research|January 12, 2025
Current Strategies and Future Dimensions in the Development of KRAS Inhibitors for Targeted Anticancer TherapyLaura D'Alessio-Sands, Joshua Gaynier, Victoria Michel-Milian, et al.
ACS Central Science|April 2, 2020
Catalysis-Enabled Access to Cryptic Geldanamycin OxidesMargaret J Hilton, Christopher M Brackett, Brandon Q Mercado, et al.
Journal of Medicinal Chemistry|August 20, 2014
Small-molecule suppression of β-lactam resistance in multidrug-resistant gram-negative pathogensChristopher M Brackett, Roberta J Melander, Il Hwan An, et al.
ACS Medicinal Chemistry Letters|March 19, 2021
Biological Evaluation of 5'-(<i>N</i>-Ethylcarboxamido)adenosine Analogues as Grp94-Selective InhibitorsDilip K Tosh, Christopher M Brackett, Young-Hwan Jung, et al.
Tetrahedron|July 19, 2016
Second Generation Modifiers of Colistin Resistance Show Enhanced Activity and Lower Inherent ToxicityChristopher M Brackett, Robert E Furlani, Ryan G Anderson, et al.
ACS Medicinal Chemistry Letters|December 20, 2023
Enniatin A Analogues as Novel Hsp90 Inhibitors that Modulate Triple-Negative Breast CancerMichael A Serwetnyk, Vincent M Crowley, Christopher M Brackett, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Current Medicinal Chemistry|August 12, 2020
Current Status of SUMOylation InhibitorsChristopher M Brackett, Brian S J Blagg
Medicinal Research Reviews|July 21, 2022
The biology and inhibition of glucose-regulated protein 94/gp96Kyler W Pugh, Marim Alnaed, Christopher M Brackett, et al.
Medchemcomm|November 20, 2012
The discovery of N-1 substituted 2-aminobenzimidazoles as zinc-dependent S. aureus biofilm inhibitorsErick A Lindsey, Christopher M Brackett, Trey Mullikin, et al.
ACS Medicinal Chemistry Letters|November 20, 2020
Synthesis and Evaluation of Ginkgolic Acid Derivatives as SUMOylation InhibitorsChristopher M Brackett, Ana García-Casas, Sonia Castillo-Lluva, et al.
Drug Development Research|January 12, 2025
Current Strategies and Future Dimensions in the Development of KRAS Inhibitors for Targeted Anticancer TherapyLaura D'Alessio-Sands, Joshua Gaynier, Victoria Michel-Milian, et al.
ACS Central Science|April 2, 2020
Catalysis-Enabled Access to Cryptic Geldanamycin OxidesMargaret J Hilton, Christopher M Brackett, Brandon Q Mercado, et al.
Journal of Medicinal Chemistry|August 20, 2014
Small-molecule suppression of β-lactam resistance in multidrug-resistant gram-negative pathogensChristopher M Brackett, Roberta J Melander, Il Hwan An, et al.
ACS Medicinal Chemistry Letters|March 19, 2021
Biological Evaluation of 5'-(<i>N</i>-Ethylcarboxamido)adenosine Analogues as Grp94-Selective InhibitorsDilip K Tosh, Christopher M Brackett, Young-Hwan Jung, et al.
Tetrahedron|July 19, 2016
Second Generation Modifiers of Colistin Resistance Show Enhanced Activity and Lower Inherent ToxicityChristopher M Brackett, Robert E Furlani, Ryan G Anderson, et al.
ACS Medicinal Chemistry Letters|December 20, 2023
Enniatin A Analogues as Novel Hsp90 Inhibitors that Modulate Triple-Negative Breast CancerMichael A Serwetnyk, Vincent M Crowley, Christopher M Brackett, et al.
Pageof 2